Your browser doesn't support javascript.
loading
The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer.
Raphael, Michael J; Raskin, William; Habbous, Steven; Tai, Xiaochen; Beca, Jaclyn; Dai, Wei F; Arias, Jessica; Forbes, Leta; Gavura, Scott; Biagi, James J; Earle, Craig C; Chan, Kelvin K W.
Afiliação
  • Raphael MJ; Division of Medical Oncology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Raskin W; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada.
  • Habbous S; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Tai X; Department of Oncology, William Osler Health System, Brampton, Ontario, Canada.
  • Beca J; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Dai WF; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Arias J; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Forbes L; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada.
  • Gavura S; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Biagi JJ; Canadian Centre for Applied Research in Cancer Control, Toronto, Ontario, Canada.
  • Earle CC; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Chan KKW; Provincial Drug Reimbursement Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
JAMA Netw Open ; 4(11): e2133388, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34779846
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Netw Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Netw Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá